Clinical Trial Update: N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update for N-acetylcysteine to prevent radiocontrast nephropathy in emergency department patients; the study has completed and results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiocontrast Nephropathy

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Radiocontrast Nephropathy | Phase 2 | Status: COMPLETED | Results posted: 2018-01-31